Log In
Print
BCIQ
Print
Print this Print this
 

MOB-015

  Manage Alerts
Collapse Summary General Information
Company Moberg Pharma AB
DescriptionTopical formulation of terbinafine
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationOnychomycosis
Indication DetailsTreat onychomycosis
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today